Salveo Biotechnology Arabia is jointly owned by JSE-listed Ecsponent Limited and international biotechnology group, Esperite. Headquartered in Switzerland and with a footprint in over 40 countries across three continents. Both cord blood and cord tissue are used for the harvesting and banking of stem cells. Cord blood stem cell transplants have already changed—and saved—thousands of lives around the world. They are used to treat more than 80 diseases, including numerous types of malignancies, anaemia’s, inherited metabolic disorders and deficiencies of the immune system. Current clinical trials are researching how stem cells may be used to manage or cure diseases and injuries such as Parkinson’s disease, type 1 diabetes, heart disease, spinal cord injury, Duchene’s muscular dystrophy, Alzheimer’s disease, strokes, burns, osteoarthritis, rheumatoid arthritis, vision, and hearing loss. Recently, bioprinting with stem cells promises a future where tissues and organs can be generated on demand rendering organ transplantation accessible with minimal complications.
